HimalayasHimalayas logo
KyvernaKY

Sr. Clinical Trial Manager

Kyverna Therapeutics is a biopharmaceutical company focused on developing innovative CAR T-cell therapies for autoimmune diseases.

Kyverna

Employee count: 51-200

Salary: 155k-180k USD

United States only

Stay safe on Himalayas

Never send money to companies. Jobs on Himalayas will never require payment from applicants.

Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible.

The Sr. Clinical Trial Manager will lead the operational delivery of one or more cell therapy clinical trials from study design through close-out. Sr. CTM will be accountable for timelines, budget, quality, vendor & CRO oversight, and cross-functional coordination for the assigned studies. Given the complexity of cell therapies (manufacturing, specialized logistics, regulatory, unique site burden), this role requires deep knowledge of clinical operations plus specific experience in cellular therapies or advanced biologics.

Title: Sr. Clinical Trial Manager

Location: Remote

Reports to: Sr. Director, Clinical Operations

Responsibilities

    • Lead and manage the day-to-day operational execution of assigned cell therapy trials: study startup, site activation, enrollment, monitoring, close-out.
    • Develop and manage study timelines, budgets, forecasts, and related operational metrics.
    • Partner with external vendors / CROs / service providers (monitoring, labs, imaging, manufacturing/supply chain for cell product) to ensure high quality and timely deliverables.
    • Serve as the primary cross-functional operational contact for study teams (clinical operations, data management, biostatistics, regulatory, safety/pharmacovigilance, manufacturing, supply chain, medical affairs, quality).
    • Ensure compliance with regulatory and quality standards (FDA, EMA, ICH-GCP, relevant local regulations) and internal SOPs.
    • Participate in protocol development and amendments, informed consent form (ICF) review, CRF/data tool development, TMF (Trial Master File) setup & maintenance, monitoring plan, data review plan, drug/cell-product accountability and reconciliation.
    • Oversee site feasibility, selection, contracting, start‐up (site initiation visits, training, enrollment & retention strategies) and close‐out activities.
    • Monitor study progress, identify risks/issues (enrollment delays, monitor/vendor performance, budget overruns, data quality issues) and implement mitigation strategies.
    • Foster effective communication across study teams, escalate issues to senior leadership as needed.
    • Ensure preparation for audits/inspections, maintain high standards of documentation readiness.
    • Contribute to lessons-learned and process improvement initiatives, particularly around cell-therapy-specific operational challenges (e.g., chain of identity/chain of custody, logistics of product, unique site training).
    • Review invoices and track study budget according to the forecast, working closely with finance and clinical business operations.
    • Develop study documents and tools including study, informed consent forms, project plans, budgets, study templates, and other materials as needed.
    • Vendor Management – Contribute to or lead cross-program vendor management activities
    • Contribute to SOP development within the Clinical Operations team

Qualifications

    • B.S. degree with minimum 7 years of experience in clinical operations including managing clinical trials in biotech, pharmaceutical.
    • Strong clinical study conduct experience from start-up through close-out.
    • Strong leadership, effective decision making, and problem-solving skills required.
    • Established Cell Therapy /CAR T study experience required.
    • Working knowledge of relevant GCPs and FDA/EMA regulations.
    • Knowledgeable of current ICH GCP guidelines and applicable regulations.
    • Ability to work effectively with minimal supervision and multi-task activities to effectively manage deliverables across all trials.
    • Experience in small/mid biotechnology environment (startup mindset)
    • Excellent written and verbal communication skills

The national base salary range for this position is $155K-$180K annually. This salary range is an estimate of what we reasonably expect to pay for this position, and the actual salary may vary based on various factors that may include but are not limited to quality and length of experience, education, geographic location and alignment with market data. This position is also eligible for bonus, benefits, and participation in the company’s stock plan.

About the job

Apply before

Posted on

Job type

Full Time

Experience level

Salary

Salary: 155k-180k USD

Education

Bachelor degree

Experience

7 years minimum

Location requirements

Hiring timezones

United States +/- 0 hours

About Kyverna

Learn more about Kyverna and their company culture.

View company profile

Our mission is to liberate autoimmune patients through the curative potential of cell therapy. A new era of CAR T-cell therapy, Kyverna is pioneering a durable disease-clearing approach aiming for deep B cell depletion, an immune system reset, and long-term remission in autoimmune diseases. We believe the success of CAR T-cell therapies in B cell-driven hematological malignancies can be leveraged to deliver therapeutic benefits in patients living with autoimmune diseases.

We are a patient-centered, clinical-stage biopharmaceutical company with active, ongoing clinical trials for multiple autoimmune diseases at different locations across the world. Our lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical development with sponsored clinical trials across two broad areas of autoimmune disease: rheumatology and neurology. This includes Phase 2 trials for stiff person syndrome, multiple sclerosis, and myasthenia gravis, as well as two ongoing multi-center, open-label Phase 1/2 trials in the United States and Germany for patients with lupus nephritis. Kyverna's pipeline includes next-generation chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats, specifically designed for use in B cell-driven autoimmune diseases.

Claim this profileKyverna logoKY

Kyverna

View company profile

Similar remote jobs

Here are other jobs you might want to apply for.

View all remote jobs

12 remote jobs at Kyverna

Explore the variety of open remote roles at Kyverna, offering flexible work options across multiple disciplines and skill levels.

View all jobs at Kyverna

Remote companies like Kyverna

Find your next opportunity by exploring profiles of companies that are similar to Kyverna. Compare culture, benefits, and job openings on Himalayas.

View all companies

Find your dream job

Sign up now and join over 100,000 remote workers who receive personalized job alerts, curated job matches, and more for free!

Sign up
Himalayas profile for an example user named Frankie Sullivan